Supporting the global life sciences industry through development and manufacturing services.
Aragen Life Sciences provides custom chemical synthesis of key starting materials (KSMs), intermediates and APIs at commercial scale for innovator and generic pharma, agrochemical and other chemical customers.
Our plants run a range of unit processes and unit operations at plant scale under varied reaction conditions. Teams monitor manufacturing and supply chain activity to support project execution and product supply.
Aragen has 2 independent facilities with 364.12 KL of aggregate installed reactor capacity as of 31 March 2026.
USFDA, EDQM, PMDA, MFDS, ANVISA, WHO Geneva, NABL, DCA, NGCMA and CDSCO
accredited facilities
2 Independent Facilities
364.12+ KL reactor volume capacity
Strong Multidisciplinary Team
of process chemists and engineers, quality control and assurance experts, EHS and engineering support
